The TPP is a missed opportunity to promote innovation on biomedical technologies. The first letter that we sent to the Canadian government and to all TPP countries nearly four years ago asked for a TPP that would promote innovation and access for all, and really brought the agenda that's been agreed and negotiated at the World Health Organization for all members states for many years for a better innovation system.
The TPP instead has created an international standard that will affect Canada as well as all the other TPP countries and beyond, because, as you know, it's an agreement that is designed to extend beyond the current 12 countries. Its aim is basically to promote and duplicate the U.S. health system and the U.S. intellectual property system abroad.